Literature DB >> 23853115

Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.

Beiyu Liu1, Igor Shats, Steven P Angus, Michael L Gatza, Joseph R Nevins.   

Abstract

Previous work has identified distinct functions for E2F proteins during a cellular proliferative response including a role for E2F1-3 in the activation of transcription at G1/S and a role for E2F4-8 in repressing the same group of E2F1-3 target genes as cells progress through S phase. We now find that E2F7 and E2F8, which are induced by E2F1-3 at G1/S, can form a heterodimer with E2F1 through interactions involving the DNA-binding domains of the two proteins. In vitro DNA interaction assays demonstrate the formation of an E2F1-E2F7 complex, as well as an E2F7-E2F7 complex on adjacent E2F-binding sites. We also show that E2F7 recruits the co-repressor C-terminal-binding protein (CtBP) and that CtBP2 is essential for E2F7 to repress E2F1 transcription. Taken together, these findings suggest a mechanism for the repression of transcription by E2F7.

Entities:  

Keywords:  Cell Cycle; DNA-binding Protein; E2F Transcription Factor; Transcription Factors; Transcription Repressor

Mesh:

Substances:

Year:  2013        PMID: 23853115      PMCID: PMC3750156          DOI: 10.1074/jbc.M113.467506

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Coordinated histone modifications mediated by a CtBP co-repressor complex.

Authors:  Yujiang Shi; Jun-ichi Sawada; Guangchao Sui; El Bachir Affar; Johnathan R Whetstine; Fei Lan; Hidesato Ogawa; Margaret Po-Shan Luke; Yoshihiro Nakatani; Yang Shi
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.

Authors:  Keigo Araki; Yusuke Nakajima; Kazuhiro Eto; Masa-Aki Ikeda
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

3.  E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.

Authors:  Luisa Di Stefano; Michael Rugaard Jensen; Kristian Helin
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

4.  Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.

Authors:  Alain de Bruin; Baidehi Maiti; Laszlo Jakoi; Cynthia Timmers; Robin Buerki; Gustavo Leone
Journal:  J Biol Chem       Date:  2003-07-31       Impact factor: 5.157

5.  Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function.

Authors:  Susanne Schlisio; Terri Halperin; Miguel Vidal; Joseph R Nevins
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

Review 6.  CtBP, an unconventional transcriptional corepressor in development and oncogenesis.

Authors:  G Chinnadurai
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

7.  Activation of the E2F transcription factor in adenovirus-infected cells involves E1A-dependent stimulation of DNA-binding activity and induction of cooperative binding mediated by an E4 gene product.

Authors:  P Raychaudhuri; S Bagchi; S D Neill; J R Nevins
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.

Authors:  K Helin; C L Wu; A R Fattaey; J A Lees; B D Dynlacht; C Ngwu; E Harlow
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

9.  E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains.

Authors:  Nicola Logan; Laurent Delavaine; Anne Graham; Carmel Reilly; Jon Wilson; Thijn R Brummelkamp; E Marielle Hijmans; René Bernards; Nicholas B La Thangue
Journal:  Oncogene       Date:  2004-07-01       Impact factor: 9.867

10.  Canonical and atypical E2Fs regulate the mammalian endocycle.

Authors:  Hui-Zi Chen; Madhu M Ouseph; Jing Li; Thierry Pécot; Veda Chokshi; Lindsey Kent; Sooin Bae; Morgan Byrne; Camille Duran; Grant Comstock; Prashant Trikha; Markus Mair; Shantibhusan Senapati; Chelsea K Martin; Sagar Gandhi; Nicholas Wilson; Bin Liu; Yi-Wen Huang; John C Thompson; Sundaresan Raman; Shantanu Singh; Marcelo Leone; Raghu Machiraju; Kun Huang; Xiaokui Mo; Soledad Fernandez; Ilona Kalaszczynska; Debra J Wolgemuth; Piotr Sicinski; Tim Huang; Victor Jin; Gustavo Leone
Journal:  Nat Cell Biol       Date:  2012-10-14       Impact factor: 28.824

View more
  21 in total

1.  An Atypical Oncogene Within the Atypical E2Fs.

Authors:  Mónica Álvarez-Fernández; Marcos Malumbres
Journal:  J Natl Cancer Inst       Date:  2015-06-18       Impact factor: 13.506

2.  CtBP2 proteome: Role of CtBP in E2F7-mediated repression and cell proliferation.

Authors:  Ling-Jun Zhao; T Subramanian; S Vijayalingam; G Chinnadurai
Journal:  Genes Cancer       Date:  2014-04

3.  Influence of GSH synthesis inhibition on temporal distribution of NAD+/NADH during vascular endothelial cells proliferation.

Authors:  C Busu; V Atanasiu; G Caldito; T Y Aw
Journal:  J Med Life       Date:  2014 Oct-Dec

4.  Transcriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity.

Authors:  Qi Liu; Pei-Fang Su; Shilin Zhao; Yu Shyr
Journal:  Genome Med       Date:  2014-12-11       Impact factor: 11.117

5.  Genome-wide analysis reveals NRP1 as a direct HIF1α-E2F7 target in the regulation of motorneuron guidance in vivo.

Authors:  Alain de Bruin; Peter W A Cornelissen; Bettina C Kirchmaier; Michal Mokry; Elhadi Iich; Ella Nirmala; Kuo-Hsuan Liang; Anna M D Végh; Koen T Scholman; Marian J Groot Koerkamp; Frank C Holstege; Edwin Cuppen; Stefan Schulte-Merker; Walbert J Bakker
Journal:  Nucleic Acids Res       Date:  2015-12-17       Impact factor: 16.971

6.  E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.

Authors:  Junjun Chu; Yinghua Zhu; Yujie Liu; Lijuan Sun; Xiaobin Lv; Yanqin Wu; Pengnan Hu; Fengxi Su; Chang Gong; Erwei Song; Bodu Liu; Qiang Liu
Journal:  Oncotarget       Date:  2015-10-13

7.  Comprehensive molecular biomarker identification in breast cancer brain metastases.

Authors:  Hans-Juergen Schulten; Mohammed Bangash; Sajjad Karim; Ashraf Dallol; Deema Hussein; Adnan Merdad; Fatma K Al-Thoubaity; Jaudah Al-Maghrabi; Awatif Jamal; Fahad Al-Ghamdi; Hani Choudhry; Saleh S Baeesa; Adeel G Chaudhary; Mohammed H Al-Qahtani
Journal:  J Transl Med       Date:  2017-12-29       Impact factor: 5.531

8.  E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer.

Authors:  Shanshan Xiang; Zheng Wang; Yuanyuan Ye; Fei Zhang; Huaifeng Li; Yang Yang; Huijie Miao; Haibin Liang; Yijian Zhang; Lin Jiang; Yunping Hu; Lei Zheng; Xiyong Liu; Yingbin Liu
Journal:  Oncogene       Date:  2018-09-25       Impact factor: 8.756

9.  Structural insights into the DNA-binding specificity of E2F family transcription factors.

Authors:  Ekaterina Morgunova; Yimeng Yin; Arttu Jolma; Kashyap Dave; Bernhard Schmierer; Alexander Popov; Nadejda Eremina; Lennart Nilsson; Jussi Taipale
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

10.  CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia.

Authors:  S A Mariani; V Minieri; M De Dominici; I Iacobucci; L F Peterson; B Calabretta
Journal:  Leukemia       Date:  2016-04-05       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.